• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Natco Pharma Limited — Board Meeting, 29-05-2026: Outcome of Board Meeting

    29-05-2026 | 02:21 pm

    NATCO Pharma's board approved Q4 & FY26 consolidated results. FY26 revenue hit ₹4,375.9 Cr, profit ₹1,418.5 Cr (includes ₹115 Cr tax benefit). Q4 profit was ₹269 Cr. Total FY26 dividend declared: ₹5/share. Board also cleared demerger of Agro Chemical business.

    No comments yet. Be the first to comment!

    All announcements from Natco Pharma Limited